Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Transradial approach to PCI, diagnostic angiography brings favorable costs, improved quality of life Erik Swain
• Achievement of target LDL particle number leads to fewer CV events James A. Underberg, MS, MD, FACP, FACPM, FNLA
• Experts debate implications of relaxed BP target for high-risk patients
• FDA approves Rebel bare-metal stent system
• FDA warning: BP kiosks not for everyone
• ECG monitors superior for detecting AF in patients with cryptogenic stroke
• AHA encourages culturally tailored heart care for Hispanic patients
• ARIC: US stroke incidence, mortality rates declined from 1987 to 2011
• Beta-blockers most effective in patients with recent MI
• Changes in pill appearance led to nonpersistence to generic drugs after MI
• Early initiation of menopausal hormone therapy did not affect atherosclerosis progression
• Empiric potassium supplementation, loop diuretics may increase survival
• Familial hypercholesterolemia guideline urges early diagnosis, treatment by specialists
• First gene linked to childhood-onset familial dilated cardiomyopathy identified
• Moderate alcohol consumption raised risk for AF
• New treatment recommendations issued for aorto-iliac PAD
• Noninvasive tool identified high coronary artery disease burden in childhood cancer survivors
• Race-based gene variations affect mortality risk among clopidogrel users
• Running, regardless of speed or duration, reduced risk for CV death
• Sitagliptin may increase hospitalizations in patients with diabetes, HF
• Study highlights sharp decline in hospitalizations for stroke, acute CVD from 1999 to 2011
• Survival after pediatric in-hospital cardiac arrest varies widely in US
• WOEST substudy: Uninterrupted oral anticoagulation did not increase bleeding, MACCE
• CardioCell launches trial to assess stem cell therapy for chronic HF
• CMS approves add-on payments for MitraClip, CardioMEMS
• ODYSSEY trials: Alirocumab met primary efficacy endpoint for LDL reduction
• MINERVA: Managed atrial, ventricular pacing reduced AF development in bradycardia
• OCT documented similarities between men, women treated with DES
• Providers reluctant to discuss end-of-life care with HF patients
• Radiation therapy examined as future treatment for AF, hypertension
• Surgeon volume increased likelihood of mitral valve repair over replacement
• Useful hypertension information common but unpopular on video-sharing websites
• Digoxin in HF: The debate continues Felix K. Yam, PharmD, MAS, BCPS; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• Trial Scorecard: ARIC
• Trial Scorecard: CHINA-PEACE
• Trial Scorecard: KEEPS
• Trial Scorecard: PRIPITENA
• Trial Scorecard: STICH
• Trial Scorecard: SWAN
• Trial Scorecard: Tele-HF
• Trial Scorecard: TRANSFER-AMI